Search research articles
Contact Us
Filters
Showing results (231-240 of 347) with videos related to
Page
of 35
Sort By:
Neurology
|
February 27, 2025
Cost Trends of New-To-Market Neurologic Medications: An Insurance Claims Database Analysis
Amanda V Gusovsky Chevalier, Chun Chieh Lin, Kevin Kerber, et al.
JAMA Neurology
|
May 10, 2016
Association of Environmental Toxins With Amyotrophic Lateral Sclerosis
Feng-Chiao Su, Stephen A Goutman, Sergey Chernyak, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
July 12, 2008
Increasing prevalence of cocaine as the primary detoxification diagnosis among admissions presenting with current intravenous drug use: a review of detoxification records from northern British Columbia, 1999-2005
Russell C Callaghan, Carol Strike, Thomas Kerr, et al.
Scientific Reports
|
May 13, 2021
Paracetamol (acetaminophen) rescues cognitive decline, neuroinflammation and cytoskeletal alterations in a model of post-operative cognitive decline (POCD) in middle-aged rats
B Garrone, L Durando, J Prenderville, et al.
Harmful Algae
|
December 5, 2025
RT-PCR assay development of ITS and toxin gene regions of, Aetokthonos hydrillicola, a known epiphyte of the invasive species Hydrilla verticillata
Theresa K Hattenrath, Erika Klar, Katherine C Callaghan, et al.
Frontiers in Neurology
|
May 6, 2014
Consumer Demand for Online Dizziness Information: If You Build it, They may Come
Kevin A Kerber, Lesli E Skolarus, Brian C Callaghan, et al.
Neurology. Clinical Practice
|
November 1, 2013
Expenditures in the elderly with peripheral neuropathy: Where should we focus cost-control efforts?
Brian C Callaghan, James F Burke, Ann Rodgers, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 8, 2021
Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status
Kai Guo, Masha G Savelieff, Amy E Rumora, et al.
Cytotechnology
|
July 6, 2017
Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2
Rosario Gil-Benso, Javier Megías, Teresa San-Miguel, et al.
Journal of Substance Abuse Treatment
|
May 31, 2008
Recovery and URICA stage-of-change scores in three marijuana treatment studies
Russell C Callaghan, Lawren Taylor, Brent A Moore, et al.
Page
of 35
Search research articles
Search
Showing results (231-240 of 347) with videos related to
Sort By:
Page
of 35
Neurology
|
February 27, 2025
Cost Trends of New-To-Market Neurologic Medications: An Insurance Claims Database Analysis
Amanda V Gusovsky Chevalier, Chun Chieh Lin, Kevin Kerber, et al.
JAMA Neurology
|
May 10, 2016
Association of Environmental Toxins With Amyotrophic Lateral Sclerosis
Feng-Chiao Su, Stephen A Goutman, Sergey Chernyak, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
July 12, 2008
Increasing prevalence of cocaine as the primary detoxification diagnosis among admissions presenting with current intravenous drug use: a review of detoxification records from northern British Columbia, 1999-2005
Russell C Callaghan, Carol Strike, Thomas Kerr, et al.
Scientific Reports
|
May 13, 2021
Paracetamol (acetaminophen) rescues cognitive decline, neuroinflammation and cytoskeletal alterations in a model of post-operative cognitive decline (POCD) in middle-aged rats
B Garrone, L Durando, J Prenderville, et al.
Harmful Algae
|
December 5, 2025
RT-PCR assay development of ITS and toxin gene regions of, Aetokthonos hydrillicola, a known epiphyte of the invasive species Hydrilla verticillata
Theresa K Hattenrath, Erika Klar, Katherine C Callaghan, et al.
Frontiers in Neurology
|
May 6, 2014
Consumer Demand for Online Dizziness Information: If You Build it, They may Come
Kevin A Kerber, Lesli E Skolarus, Brian C Callaghan, et al.
Neurology. Clinical Practice
|
November 1, 2013
Expenditures in the elderly with peripheral neuropathy: Where should we focus cost-control efforts?
Brian C Callaghan, James F Burke, Ann Rodgers, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 8, 2021
Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status
Kai Guo, Masha G Savelieff, Amy E Rumora, et al.
Cytotechnology
|
July 6, 2017
Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2
Rosario Gil-Benso, Javier Megías, Teresa San-Miguel, et al.
Journal of Substance Abuse Treatment
|
May 31, 2008
Recovery and URICA stage-of-change scores in three marijuana treatment studies
Russell C Callaghan, Lawren Taylor, Brent A Moore, et al.
Page
of 35